... DNA damage or activation of cancer-promoting genes, or oncogenes.
Lozano, an expert on mouse models ... p53H mutation on both genes (p53 H/H), the researchers found that the p53 protein was not detectable ...
... cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston. Introgen ... a modified adenovirus that expresses the tumor-suppressing gene p53, for end-stage head and neck ...
... known for two decades to be the master gatekeeper that controls all cancer development. When gene p53 is defective, it loses its ability to regulate healthy cells and suppress cancer.
"Until now, ...
... numerous in human bladder cancer and in 2004 reported that it destabilizes and inhibits the cancer-fighting gene p53.
Building on this work, the team analyzed 15 paired samples of bladder cancer and ...
[PRESS RELEASE, 27 February 2009] Gene p53 protects against cancer and is usually ... influence of their end products – usually proteins – on gene expression. With antisense regulation, control is effected ...
Gene p53 protects against cancer and is usually described as the most important gene in cancer research. ... first to show how antisense RNA regulates genes in the human body. It is already a well-known ...
... both of these processes are regulated by the tumor suppressor gene p53 that is commonly mutated in human prostate ... hold true, tumor cells with intact p53 may show the best response to therapy targeting ...
... While the precise causes of osteosarcoma are unknown, it is evident that two tumor suppressor genes – p53 and Rb – are involved, as children with familial mutation syndromes affecting either of these ...
... molecule drug that targets the most common mutated gene, p53, in human cancer cells, has potential ... dependent on estrogens and progestins for growth."
Mutated p53 plays a key role in promoting tumor ...
... a University of Missouri study suggests that PRIMA-1, a small molecule drug that targets the most common mutated gene, p53, in human cancer cells, has potential as a novel chemotherapeutic ...
... . Now, a new study suggests that PRIMA-1, a small molecule drug that targets the most common mutated gene, p53, in human cancer cells, has potential as a novel chemotherapeutic ...
... to demonstrate that two major tumor suppressor genes, p53 and PTEN, are inactivated in invasive bladder ... a paper in the March 15, 2009 issue of Genes & Development. The new model disrupts a signaling ...
... ratchets down the activity of the tumor-suppressor gene p53, according to a study by Whitehead Institute and National ... several types of cells known to express p53, including human neural and lung cells ...
... to activate NF-kappaB in mouse lung tumors: expression of
the cancer gene ras, and loss of the tumor suppressor gene p53.
They also showed that inhibition of NF-kappaB in mice with that
...
